Fractyl Health (GUTS) Total Debt (2023 - 2026)
Fractyl Health (GUTS) reported Total Debt of $30.1 million for Q1 2026, up 2.56% year-on-year from $29.4 million in Q1 2025, and down 1.47% quarter-over-quarter from $30.6 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Total Debt data on file, last reported at $30.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt rose 2.56% year-over-year to $30.1 million; the trailing twelve-month figure through Mar 2026 stood at $30.1 million (up 2.56% YoY), and the FY2025 full-year result was $30.6 million, up 1.41% from the prior year.
- Total Debt for Q1 2026 stood at $30.1 million, down from $30.6 million in the prior quarter.
- Across five years, Total Debt topped out at $55.2 million in Q4 2023 and bottomed at $28.4 million in Q2 2024.
- A 4-year average of $32.4 million and a median of $30.1 million in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt tumbled 45.31% in 2024 and advanced 5.7% in 2025, its largest moves.
- Tracing GUTS's Total Debt over 4 years: stood at $55.2 million in 2023, then tumbled by 45.31% to $30.2 million in 2024, then gained by 1.41% to $30.6 million in 2025, then slipped by 1.47% to $30.1 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $30.1 million, $30.6 million, and $30.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 1.99 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 30.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.14 Mn |
| Dec 31, 2025 | 30.59 Mn |
| Sep 30, 2025 | 30.77 Mn |
| Jun 30, 2025 | 29.99 Mn |
| Mar 31, 2025 | 29.39 Mn |
| Dec 31, 2024 | 30.16 Mn |
| Sep 30, 2024 | 30.32 Mn |
| Jun 30, 2024 | 28.37 Mn |
| Mar 31, 2024 | 28.70 Mn |
| Dec 31, 2023 | 55.15 Mn |